Tag: combination products
Bioequivalence of Combination Products: Special Testing Challenges
Bioequivalence testing for combination products like fixed-dose combos and drug-device systems faces unique scientific and regulatory hurdles. Unlike single-drug generics, proving sameness requires complex studies, inconsistent methods, and costly trials-delaying affordable access for patients.
Read more